FDA Inspection 1265869 — CA BOTANA International, Inc.

CA BOTANA International, Inc. — FEI 2023910

The FDA completed an inspection of CA BOTANA International, Inc. on April 4, 2025 in San Diego, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 4, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Diego, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
184221 CFR 211.84(d)(1)Component identity verification
189121 CFR 211.165(f)Failing drug products not rejected
360321 CFR 211.160(b)Scientifically sound laboratory controls